We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

221 hedge funds and large institutions have $674M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

92,654% more call options, than puts

Call options by funds: $46.4M | Put options by funds: $50K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 226 → 221 (-5)

5.47% less ownership

Funds ownership: 107.8% → 102.34% (-5.5%)

10% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 77

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

40% less capital invested

Capital invested by funds: $1.12B → $674M (-$443M)

Holders
221
Holders Change
-5
Holders Change %
-2.21%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
69
Reduced
77
Closed
44
Calls
$46.4M
Puts
$50K
Net Calls
+$46.3M
Net Calls Change
-$27.1M

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12.8M
2
KCM
Kynam Capital Management
New Jersey
+$11M
3
SCM
Stonepine Capital Management
Oregon
+$5.12M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.23M
5
State Street
State Street
Massachusetts
+$3.64M

Top Sellers

1
BCM
Brown Capital Management
Maryland
-$16.8M
2
Man Group
Man Group
United Kingdom
-$11.2M
3
GT
Glenmede Trust
Pennsylvania
-$9.1M
4
JP Morgan Chase
JP Morgan Chase
New York
-$8.31M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
YIH
226
Y-Intercept (HK)
Hong Kong
– -$1.24M -189,962 Closed
HIM
227
Hillsdale Investment Management
Ontario, Canada
– -$1.07M -164,800 Closed
AACP
228
Advantage Alpha Capital Partners
California
– -$773K -118,514 Closed
AG
229
Artal Group
Luxembourg
– -$721K -110,532 Closed
Wellington Management Group
230
Wellington Management Group
Massachusetts
– -$714K -109,495 Closed
Squarepoint
231
Squarepoint
New York
– -$688K -105,566 Closed
SIM
232
SummerHaven Investment Management
Connecticut
– -$470K -72,030 Closed
BHCM
233
Brevan Howard Capital Management
Jersey
– -$445K -68,200 Closed
OA
234
Oak Associates
Ohio
– -$400K -61,384 Closed
HF
235
HRT Financial
New York
– -$392K -60,271 Closed
American Century Companies
236
American Century Companies
Missouri
– -$376K -57,624 Closed
IVP
237
Intrinsic Value Partners
Arizona
– -$296K -45,435 Closed
CL
238
Choreo LLC
Illinois
– -$292K -44,839 Closed
I
239
InceptionR
California
– -$241K -36,926 Closed
UM
240
UniSuper Management
Australia
– -$230K -35,307 Closed
EGM
241
Engineers Gate Manager
New York
– -$215K -33,046 Closed
Axa
242
Axa
France
– -$184K -28,168 Closed
ET
243
Entropy Technologies
New York
– -$177K -27,179 Closed
NVCHI
244
New Vernon Capital Holdings II
New Jersey
– -$141K -21,572 Closed
FRM
245
Fox Run Management
Connecticut
– -$138K -21,141 Closed
Capstone Investment Advisors
246
Capstone Investment Advisors
New York
– -$130K -19,876 Closed
Envestnet Asset Management
247
Envestnet Asset Management
Illinois
– -$123K -18,935 Closed
SG Americas Securities
248
SG Americas Securities
New York
– -$122K -18,769 Closed
LCM
249
Laurion Capital Management
New York
– -$110K -16,841 Closed
GHA
250
GW Henssler & Associates
Georgia
– -$96.7K -14,828 Closed
7 8 9
10
11

IRWD Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2024, worth a combined $674M — down 40% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IRWD and 39 opened new positions — a net loss of 5 holders — while 77 trimmed existing stakes and 69 added.

The largest buyer was Pacer Advisors, adding an estimated $12.8M. The largest seller was Brown Capital Management, exiting entirely with an estimated $16.8M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2024, down from 226 in Q2 2024.
  • Funds reported $674M of Ironwood Pharmaceuticals stock for Q3 2024, down 40% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q3 2024 and 44 closed out, a net change of -5 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2024 was Pacer Advisors, an estimated $12.8M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2024 was Brown Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.